1. Home
  2. MXCT vs SJT Comparison

MXCT vs SJT Comparison

Compare MXCT & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

SELL

Current Price

$1.38

Market Cap

155.8M

Sector

Health Care

ML Signal

SELL

SJT

San Juan Basin Royalty Trust

SELL

Current Price

$4.43

Market Cap

139.8M

Sector

Energy

ML Signal

SELL

Company Overview

Basic Information
Metric
MXCT
SJT
Founded
1999
1980
Country
United States
United States
Employees
N/A
495
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
155.8M
139.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MXCT
SJT
Price
$1.38
$4.43
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $4.11
N/A
AVG Volume (30 Days)
★ 1.4M
289.8K
Earning Date
11-10-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $33,026,000.00
N/A
Revenue This Year
$4.77
N/A
Revenue Next Year
$10.06
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.64
$2.37
52 Week High
$1.80
$6.27

Technical Indicators

Market Signals
Indicator
MXCT
SJT
Relative Strength Index (RSI) 55.07 58.38
Support Level $1.02 $4.13
Resistance Level $1.54 $4.69
Average True Range (ATR) 0.14 0.42
MACD -0.01 0.11
Stochastic Oscillator 70.41 68.17

Price Performance

Historical Comparison
MXCT
SJT

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About SJT San Juan Basin Royalty Trust

San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.

Share on Social Networks: